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Abstract
OBJECTIVES: The main reason for aortic repair failures is recurrent annular dilatation. The fibrous portion of left ventricular outflow tract
dilates. A novel device was designed to tackle this problem.
METHODS: The device consists of an internal ring applied at the aortic annulus plus an external flexible band at the level of the aortic
root. The internal ring has a semi-rigid portion (40%, placed at ventriculo-arterial junction) and a flexible portion to allow it to conform
along the curves of the non-coronary/right coronary leaflet and right coronary/left coronary leaflet commissures. The external band acts
as a reinforcement to the internal ring. A pulsatile mock loop capable of housing porcine aortic valve was used. Working conditions were
60 bpm of heart rate, 75 of stroke volumes and 120–80 mmHg of simulated pressure. Mean gradient, effective orifice area, annular diam-
eter, coaptation height and length were recorded on 11 aortic root units (ARUs). High-speed video and standard echocardiographic
images were also recorded. All data were acquired in the following conditions: (i) basal (untreated ARU); (ii) pathological condition (left
coronary/non-coronary triangle was dilated by suturing an aortic patch); and (iii) ARU treated with the device.
RESULTS: Gradients and effective orifice area were respectively 0.9 ± 0.64 mmHg and 3.1 ± 0.7cm2 (pathological) and 3.7 ± 1.1 mmHg and
1.5 ± 0.2cm2 (treated, P < 0.05). Left coronary/non-coronary diameter decreased from 2.4 ± 0.2 cm (pathological) to 2.0 ± 0.2 (treated,
P < 0.05). Coaptation length and height were fully restored to basal values following treatment. Visual inspection showed proper dynamics
of the leaflet, confirmed by high-speed video and echocardiography.
CONCLUSIONS: The device allowed for restoring physiologic-like coaptation in the experimental model, without inducing clinically rele-
vant worsening of the haemodynamics of the treated ARU.
Keywords: Aortic valve • Aortic valve repair • Annuloplasty ring
INTRODUCTION
Aortic valve (AV) repair is considered as an alternative to AV
replacement for pure aortic regurgitation (AR) [1, 2]. In patients
with AR, the degree of ventriculo-aortic junction dilatation correl-
ates with the severity of AR resulting from improper leaflet coapta-
tion [3]. AV repair is not widely performed due to difficulties to
treat leaflet prolapse, annular dilatation, STJ dilatations, ascending
aorta dilatation and combined disease in a complex structure, as it
is the aortic root unit (ARU) [4]. Mid-term results of AV repair are
promising, but recurrence of AR has been reported at times
related to dilatation of ventriculo-arterial junction (VAJ) not only in
valve preserving but also in primary AV repair procedures [5–9]. In
mitral repair surgery, prosthetic annuloplasty ring in addition to
reparative procedure is a well-established concept [10].
The current annuloplasty in use are the following: (i) subcom-
missural annuloplasty, as advocated by Cabrol et al. [11], which
involves constriction of interleaflet triangle. It is a simple and an
effective technique, but does not touch the problem of annular
dilatation resulting in recurrent annular dilatation and
reoperation [6, 9]; (ii) external ring by Lansac et al. [12]: this ap-
proach has reported acceptable 5-year results but has not gained
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popularity as external rings are difficult to place at the annular
plane along the muscular ridge of the right coronary (RC) leaflet;
and (iii) Rankin ring [13]: acceptable 2-year follow-up was
published. This ring has elliptical base geometry and subcommis-
sural posts, giving it a crown-shaped appearance similar to nor-
mal AV. The concept is based on the fact that all 3
intercommissural triangles are equal, which is not always the
case. In particular, in bicuspid valves, the annulus is asymmetric-
ally dilated and deeper at the aortomitral curtain, rendering in-
sertion of this ring not ideal. Similar issues exist when this
approach is applied to Marfan patients [14].
None of these approaches is conceived considering the het-
erogeneous biomechanical properties of the aortic annulus
(defined as the virtual basal plane along the nadir of the 3 leaf-
lets), which reflects on asymmetrical dilation. The dilatation
occurs along the fibrous portion of the left ventricular outflow
tract. The fibrous portion comprises the following: (i) interleaflet
triangle along non-coronary (NC)/left coronary (LC) leaflets and
the area of fibrous continuity between the leaflets of the aortic
and mitral valves or VAJ; (ii) the membranous portion between
the RC and NC leaflets that, in continuity with the right fibrous
trigone, forms the ‘central fibrous body’. They are positioned be-
tween the semilunar hinges of the leaflets as they extend to insert
to the sinutubular junction. Muscular portion typically does not
dilate. So, in most of the pathologies like Marfan, bicuspid valve,
annulo-aortic ectasia and other connective tissue disorders, the
annular dilatation will be asymmetrical, unless in case of very
advanced disease [15].
Ideally, an annular system for treating aortic annular dilation
should be designed considering the following: (i) the annular dy-
namics of contractions and relaxations during the cardiac cycle;
(ii) the 3D shape of the aortic annulus; (iii) the anatomical–func-
tional constrains (e.g. the conduction bundle between the RC
and NC leaflets); and (iv) the differences in annular tissues in
terms of composition (fibrous or muscular).
In this paper, a novel aortic annular system (AAS) had been de-
signed, taking into account the above-presented issues. The pur-
pose of the study was to evaluate the effect of the device
implantation on AV functioning and haemodynamics. For that
purpose, the device was implanted in dilated swine aortic roots.
Fluid dynamics and echocardiographic data pre- and post-
implantation were acquired and compared.
MATERIALS AND METHODS
Design principles of the device
The AAS consists of an internal ring designed to be applied at the
aortic annular level, plus an external flexible band to be applied
at the level of the aortic root. The internal ring is oval, with a
semi-rigid 40% part of its perimeter designed to be placed at the
VAJ or the plane of mitral–aortic continuity (Fig. 1). The remain-
ing portion of the ring is flexible and designed to be placed at
the muscular and membranous portion of the annulus. The flex-
ible portion of the ring features an extra 5% length to the normal
60% of its perimeter to allow for it to conform along the curves
of NC/RC leaflets (membranous) and RC/LC leaflets commissures
(muscular) (Fig. 1, dotted lines). The external band is intended as
a reinforcement to the internal ring. These dimensions are based
on how each portion is represented in the human left ventricular
outflow tract [16, 17].
Manufacturing details
The semi-rigid portion of the ring consists of a 0.8-mm (0.03000)
diameter MP35N wire embedded within a silicone elastomer
with a shore hardness of 30 A. The flexible portion is made en-
tirely of silicone elastomer. The whole ring is encased within a
polyethylene terephthalate circular knit tube. The band is made
up of a 5.6-mm (0.21900)-wide polyethylene terephthalate knit
fabric. Eleven rings with a diameter of 21 mm (0.82700) were used
for this study.
The ring was secured to a plastic holder, which snapped onto a
stainless steel handle to facilitate positioning (Fig. 2). The ring was
located below the aortic leaflets, and the band was positioned op-
posite to the ring and external to the aortic root. The ring, band
and aortic tissue were attached together with sutures. Parts were
manufactured at BOMImed Inc. (Winnipeg, MB, Canada).
Suturing technique
The suturing technique scheme is shown in Fig. 3. The fibrous
portion of the annulus lies below the NC/LC leaflets, the muscu-
lar portion below the LC/RC leaflets and the membranous
Figure 1: Internal suture line for the aortic annular system. NC: non-coronary leaflet; LC: left coronary leaflet; RC: right coronary leaflet.
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portion below the RC/NC leaflets. The semi-rigid (grey) portion
of the ring is placed at the VAJ in a straight line to allow the max-
imum annular reduction, while the flexible (white) portion goes
up along the commissures of NC/RC and LC/RC leaflets to avoid
membranous septum and away from muscular septum (Fig. 1). In
the semi-rigid portion of the ring, the U sutures were 2 mm wide
at ring, wider apart at the fibrous annulus to allow annular
reduction and went back to 2 mm on the external band. In the
flexible portion, sutures were 2 mm wide in ring, annulus and
band. The external band was divided twice at the level of the cor-
onary ostia. The ring was lowered to the annular plane prior to
removing the holder, and then the sutures were passed through
the band. The sutures were first tied at the fibrous annulus and
nadir of the RC leaflet and then the rest of the sutures were tied.
Experimental apparatus
A pulsatile mock loop capable of housing swine ARUs was used for
the experimental model [18, 19]. Figure 4 reports a schematic of
the mock loop. The pulsatile flow was pushed by the pump d
through the ARU sample a. The flow entered the afterload e that
mimic the systemic input impedance, to guarantee a physiologic-
like systemic pressure to the sample a. The fluid passed from e to
the atrial bath b and returned to the ventricle c through a service
valve (in red) acting as mitral valve, thus closing the hydraulic ring.
The experimental apparatus allowed for measuring and recording
pressure downstream to and upstream from the ARU (p1 and p2 re-
spectively) as well as the flow rate downstream from the ARU (Q).
The swine ARUs were selected according to the size of the AAS
(21 mm) available for the study. The ARU sizing procedure wasFigure 2: Complete assembly of the device with the holder.
Figure 3: The suturing technique is shown. The flexible portion of the internal ring is in white, while the semi-rigid part is in grey. NC: non-coronary leaflet; LC: left
coronary leaflet; RC: right coronary leaflet.
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comparable to the sizing procedure adopted in the operating
room and was performed by experienced surgeons.
Each ARU was housed in the test section of the mock loop in
basal condition and tested. Then, the pathological condition and
the treated condition were obtained in each ARU. In each of
these 2 configurations, the ARU was tested again, in the same
mock loop settings, and data were acquired.
Pathological model for aortic valve dilatation
The strategy to get the pathological model of swine ARU was
taken from the literature [20]. A 15-mm-long cut in the ARU axial
direction was performed in correspondence with the intercom-
missural triangle between LC and NC leaflets (Fig. 5A). The cut
was from the top of the NC/LC leaflet commissure to the anterior
mitral leaflet. A rhomboidal patch of tissue was harvested from
the porcine aorta and sutured according to the cut (Fig. 5B).
Approximate dimensions of the patch were 10 mm (ARU circum-
ferential direction) and 15 mm (axial direction), to allow for the
sample to dilate circumferentially.
Test methods and procedure
Eleven AASs of size 21 mm were tested in selected swine ARUs.
The size of the annulus was measured by standard St Jude
Medical aortic sizers. The AASs were implanted by a cardiac sur-
geon. A single-operator implanting strategy was adopted to
avoid inter-operator bias.
Two kinds of tests (A and B, respectively) were performed.
Tests A were designed to investigate the effect of AAS implant-
ation on the ARUs in terms of fluid dynamic alteration and coap-
tation/function of the AV. Tests B were designed to investigate
the fluid dynamic performance of the treated ARUs when tested
at increasing SVs.
Test A. The following conditions were tested in sequence for
each ARU:
a. Basal condition. The ARU was tested in untreated condition
so as to record the main biomechanical parameters in
physiologic-like conditions.
Figure 4: Schematic of the experimental apparatus. a: porcine aortic root unit; b: atrial bath; c: ventricular chamber; d: pulsatile pump; e: systemic input impedance
simulator; p1, p2: aortic and ventricular pressure ports, respectively; Q: flowmeter probe.
Figure 5: Surgical preparation of the dilated aortic root. (A) A surgical cut (about 15-mm axial length) was performed in correspondence to the left coronary and non-
coronary intercommissural triangle. (B) A patch obtained from the aorta was sutured in correspondence to the cut. Maximum circumferential dimension of the patch
was approximatively 10 mm, to allow for the root to dilate.
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b. Pathological condition. The pathology was simulated in the
ex vivo ARU model, as described earlier, to have a model of
dilated root. The ARU was tested in these conditions.
c. Treated condition. The AAS was implanted in the pathological
model of ARU and tests were run again with data acquisition.
Mock loop was set at 60 bpm, with a stroke volume (SV) of
75 ml and a systolic/diastolic systemic pressure of 120/80 mmHg.
In each condition, the pressures upstream from and downstream
to the ARU, and the flow rate across the ARU were acquired.
From the raw experimental data, the following measurements
were obtained and compared in the 3 conditions a, b and c:
• CO: cardiac output, l/min: mean flow rate evaluated from the
Q measured downstream from the ARU.
• Dpmax, mmHg: maximum systolic pressure drop (from p1 and
p2).
• Dpmean, mmHg: mean systolic pressure drop (from p1 and p2).
• EOA, cm2: effective orifice area, evaluated as follows [4]:
EOA=
Qrms
k
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DPm
p ;
where Qrms (l/min) was the mean square root of the systolic flow
rate, DPm (mmHg) the mean systolic pressure drop across the
sample and k a conversion factor (k = 3.1 to yield the EOA in
square centimetre).
Echocardiographic images were acquired to evaluate the mor-
phological differences between basal, pathological and treated
conditions in terms of a geometric orifice area (GOA), coaptation
height, coaptation length and aortic annulus. The geometric ori-
fice area was evaluated in short axis, at the maximum valve
opening, measuring the area of the opening orifice. Long-axis
images of the 3 coaptation surfaces (NC/LC, NC/RC and RC/LC
leaflets) were acquired and, for each of them, the annulus
(defined as the distance between the 2 leaflets nadir), the coapta-
tion height (i.e. the distance between the tip of the coaptation
and the annular plane) and the coaptation length (the distance in
which the 2 leaflets coaptation) were evaluated. All echo evalu-
ations were performed by the same operator.
Values were averaged over 10 simulated cardiac cycles and
were reported as mean and standard deviation. A total of 11
ARUs were tested in this series.
Test B. Of the 11 ARUs, 7 were tested, only in treated conditions
(c), with the mock loop set to 60 bpm, 120/80 mmHg of systemic
pressure and the SV set at 55 ml, 75 ml and 95 ml. The purpose of
these tests was to evaluate the hydrodynamic performance of the
device simulating different patient/device mismatch. In these ex-
perimental conditions, the CO, pmax, and pmean were evaluated.
Statistical analysis
Ten consecutive simulated cycles in each experimental point
were analysed to obtain fluid dynamic data for each tested ex-
perimental point. Overall data were presented as mean ± stand-
ard deviation following the assessment of normal distribution.
Statistical significance (P < 0.05) was evaluated using repeated-
measures analysis of variance and with Bonferroni’s post hoc
test.
RESULTS
Pooled data for the Tests A and B are reported below.
Test A
Fluid dynamics. Main fluid dynamic findings are reported in
Fig. 6 (means with standard deviation as error bars). The CO
slightly decreased following ARUs enlargement (from
3.65 ± 0.21 l/min, basal, to 3.30 ± 0.30 l/min, pathological,
P < 0.05). Annular enlargement did not change the maximum nor
mean systolic pressure drop across the ARU, as expected. The im-
plantation of the AAS induced statistically significant (P < 0.05) in-
crement of pmax (from 17.30 ± 1.7 mmHg, pathological, to
21.11 ± 4.6 mmHg post-treatment) and pmean (from
0.94 ± 0.43 mmHg to 3.65 ± 1.07 mmHg post-treatment). EOA
decreased from 5.37 ± 1.21 cm2 to 2.62 ± 0.34 cm2 following the
treatment (P < 0.05).
Echocardiographic data. Echocardiographic data described
the variation of coaptation geometry when passing from
the physiologic ARUs to the pathological and to the treated ARUs
(Fig. 7). The pathological model induced a statistically signficant re-
duction of coaptation length as well as copatation height in the
ARUs, regardless of the couple of leaflets used as a reference for
the echographic evaluation. The treatment allowed for a complete
recovery of these quantities to the values recorded in basal ARUs.
With regard to annular diameter, the annulus enlarged in LC-
NC direction (pathological) compared to basal state (P < 0.05).
This enlargement returned to basal following AAS treatment. The
geometric orifice area decreased from 4.83 ± 0.65 cm2 (patho-
logical) to 3.85 ± 0.76 cm2 following treatment (P < 0.05).
Test B
These tests (Fig. 8) at different SVs were performed only on the
treated ARUs. The CO increased from 2.43 ± 0.29 mmHg
(SV = 55 ml) to 4.83 ± 0.46 ml (SV = 95 ml), P < 0.05. The maximum
pressure increased from 13.27 ± 1.26 mmHg (minimum SV) to
23.33 ± 1.47 mmHg (maximum SV, P < 0.05), and the mean sys-
tolic pressure increased from 0.73 ± 0.42 mmHg (minimum SV) to
5.70 ± 0.92 mmHg (maximum SV, P < 0.05).
DISCUSSION
In this work, a novel device for the treatment of aortic annular
dilation is presented. The device consisted of an internal ring
oval in shape. A semi-rigid portion of the ring was placed at the
VAJ to reduce, prevent further dilatation and give stability. A flex-
ible portion of the ring was designed to confer along the curves
of NC/RC and LC/RC leaflets to protect the conduction bundle
and allow dynamic motion of the annulus during cardiac cycle.
Dedicated in vivo tests will allow for an experimental assessment
of the residual risk of atrioventricular block associated with this
design. A flexible external band was intended to reinforce and in-
crease the strength of the entire system. Tested in an ex vivo ex-
perimental set-up, the device allowed for a full recovery of the
leaflet coaptation, without inducing clinically relevant alteration
to the AV functioning and haemodynamics.
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An established experimental approach was adopted to assess
primarily the impact of the implantation of the novel device on
valve haemodynamics. Indeed, it is well recognized that an in-
crease in pressure drop, following treatment, is associated with
valve replacement and as well with AV annuloplasty [18, 19].
Following the assessment of the haemodynamic performance of
the treatment, the pathological model of the ARU allowed us to
assess the potential of the applied device in restoring the correct
leaflet coaptation length and height in an experimental model
that represents the immediate postoperative scenario.
Figure 6: Hydrodynamic findings: cardiac output (CO, l/min), maximum and mean systolic pressure drop (pmax and pmean mmHg) and effective orifice area (EOA,
cm2) measured in simulated physiological, pathological and post-treatment conditions. Mean ± SD (bars) evaluated over 11 samples are reported. Star indicates statis-
tical significance (P < 0.05).
Figure 7: Echocardiographic main findings. Coaptation length and height are evaluated in simulated physiological, pathological and treated conditions between the
(LC-NC), LC-RC and RC-NC leaflets. Mean ± SD (bars) evaluated over 11 samples are reported. Star indicates statistical significance (P < 0.05). LC-NC: left coronary/
non-coronary; LC-RC: left coronary/right coronary; RC-NC: right coronary-non coronary; GOA: geometric area orifice.
EX
P
ER
IM
EN
TA
L
1095P. Shah et al. / European Journal of Cardio-Thoracic Surgery
D
ow
nloaded from
 https://academ
ic.oup.com
/ejcts/article-abstract/52/6/1090/3868556 by U
niversità degli Studi di M
ilano user on 09 O
ctober 2019
Ex vivo test methodology
The proposed approach to obtain dilated swine ARUs was taken
from the literature [20]. The methodology allowed to get a statistic-
ally significant dilation of the interleaflet triangle between the LC
and the NC leaflets, coherently with the triangle that was enlarged
in this experimental model. This resulted in significantly reduced
coaptation length and height. The model did not induce AR and
thus did not cause significant alteration in CO with respect to the
physiological conditions. This means that the imposed dilation did
not allow complete loss coaptation between the leaflets.
Haemodynamic findings
Following treatment, a significant increase in both maximum and
mean systolic pressure drops with respect to untreated and
pathological conditions was measured. This means that the in-
ternal ring induced a degree of interference with the haemo-
dynamics. Of note, the absolute values of the pressure drop
never reached clinically relevant values, and where lower, with
respect to data reported in the literature concerning in vitro tests
of state-of-the-art bioprostheses designed for the same size [19].
Moreover, it should be considered that a physiological SV for
21 mm ARU should be between 55 ml and 75 ml [19], when a
mean pressure increase ranging from 0.73 ± 0.42 mmHg to
3.38 ± 0.59 mmHg was recorded. The maximum tested SV of
95 ml represented a simulation of mismatch between the treated
ARU and the patient, and the recorded mean pressure drop in
these conditions (5.70 ± 0.92 mmHg) was not of clinical relevance.
The EOA decreased following treatment: basal values were similar
to reports from the literature and values for treated ARUs were
similar to data reported for VAJ annuloplasty [18] and biopros-
theses [19] evaluated in the same experimental scenario.
Echocardiographic findings
Following the treatment of the pathological ARUs, the coaptation
geometric parameters were restored to their original physio-
logical values. In particular, no statistically significant differences
were obtained in coaptation lengths and heights between basal
and treated ARU. Of note, the coaptation lengths were higher in
treated model with respect to the basal state. This increased co-
aptation could provide a functional reserve that might correlate
with a stable valve functioning over the time.
Limitations
The proposed methodology suffered from the limitations of the ex
vivo approaches. First, it allowed for the investigation of a scenario
that replicates the acute postoperative conditions. Thus, we assessed
that the proposed treatment did not alter the valve haemodynamics
and functioning in the treated model, with a proper coaptation of
the valve. Mid- to long-term outcomes require specific in vivo inves-
tigations to assess implant durability and the associated risk of leaflet
damage due to the internal ring placement. A second limitation of
the study relies in the fact that the ARU lost all its muscle activity in
the experimental set-up. This muscle activity induces ventriculo-
aortic junction shape alteration during the cardiac cycle. These
alterations could in turn have an effect on the haemodynamics and
leaflet coaptation. Another limitation of the study relies in the ana-
tomical differences between swine and human aortic root. Despite
the swine model is often used in ex vivo studies, some anatomical
peculiarities are a limiting factor in this study. For example, the de-
sign of the pathological model with only NC/LC intercommissural
triangle dilation replicates a specific model of annulo-aortic ectasia.
In the real settings, often the RC/NC intercommissural triangle also
dilates. The swine aortic root, which has a pronounced muscular
shelf in this zone, did not allow for a controllable ex vivo dilation
with the surgical patch adopted in this work. Both these limitations
could be addressed in targeted tests on animal models.
CONCLUSIONS
The work demonstrates in an ex vivo acute experimental set-up
that the novel device does not induce clinically relevant impair-
ment to the haemodynamics and can restore correct coaptation
length and height in dilated aortic annulus. It did not affect valve
motion on visual inspection, high-speed video or on echocardi-
ography. This study can be considered a promising starting point
for further evaluation of the approach, aimed at assessing treat-
ment durability and efficacy over the time.
Figure 8: Hydrodynamic findings in post-treatment samples evaluated for
different imposed stroke volumes (55, 75 and 95 ml): cardiac output (CO,
l/min), maximum and mean systolic pressure drop (pmax and pmean mmHg).
Mean ± SD (bars) evaluated over 7 samples are reported. Star indicates statis-
tical significance (P < 0.05).
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